Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Vet Pharmacol Ther ; 39(2): 196-8, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26202842

RESUMO

Pregnancy induces several physiologic changes that might impact the bioavailability, distribution, metabolism, and excretion of drugs. The objective of this study was to determine the effects of pregnancy on the disposition of oral firocoxib in mares. Seven pony mares received oral firocoxib paste at a dose of 0.1 mg/kg during late pregnancy and again 12 to 33 days postpartum. Firocoxib concentrations were measured in plasma by HPLC with ultraviolet detection. Maximum plasma concentrations were significantly lower in pregnant (50.0 ± 21.8 ng/mL) than in postpartum (73.7 ± 25.6 ng/mL) mares. Plasma concentrations 24 h after administration, time to maximum plasma concentrations, and area under the plasma concentration versus time curve were not significantly different between late pregnancy and the postpartum period in mares.


Assuntos
4-Butirolactona/análogos & derivados , Inibidores de Ciclo-Oxigenase 2/farmacocinética , Cavalos/metabolismo , Período Pós-Parto/metabolismo , Prenhez , Sulfonas/farmacocinética , 4-Butirolactona/farmacocinética , Animais , Área Sob a Curva , Feminino , Gravidez , Distribuição Tecidual
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA